News

quality improvement QI artificial intelligence AI healthcare

Within healthcare, artificial intelligence and quality improvement have some things in common. 

UnitedHealthcare UHC UnitedHealth

In a new report, the New York Times details multiple incidents of the insurance giant using legal threats to silence social media users and news outlets, citing the murder of Brian Thompson and the threat of rising violence as the basis for its claims. 

medical debt

The Consumer Financial Protection Bureau joined trade lobby groups in asking a federal court to vacate the rule, which would have forbidden creditors from considering medical debt in lending decisions.

Under the direction of U.S. Attorney General Pam Bondi, charges against Michael Kirk Moore Jr., MD, were dropped just as his trial began. He had been accused of destroying 1,937 doses of COVID-19 vaccines and accepting kickbacks for falsifying vaccine records.

The late-breaking U.S. multicenter admIRE clinical trial at the Heart Rhythm Society 2024 meeting, showed positive data on the long-term safety and effectiveness of the the Biosense Webster Varipulse pulsed field ablation (PFA) system in patients with paroxysmal atrial fibrillation. #HRS #HRS2024 #PFA

The Varipulse PFA platform originally gained FDA approval in 2024. According to Johnson & Johnson MedTech, this update was put in place to help the technology provide better patient outcomes going forward.

Ultromics EchoGo Amyloidosis artificial intelligence

The first FDA-cleared AI model of its kind was found to be an accurate screening tool for cardiac amyloidosis.

Bayer finerenone Kerendia heart failure MOONRAKER

Finerenone, sold by Bayer under the brand name Kerendia, is now approved in the United States for the treatment of HFmrEF and HFpEF. The drug has already been used for years to treat patients with chronic kidney disease and type 2 diabetes.

Edwards Lifesciences has recalled more than 61,000 medical devices due to the risk of a small piece of wire becoming exposed. No patient injuries have been reported at this time.

Eko Health, the California-based healthcare technology company known for its advanced stethoscopes, has received U.S. Food and Drug Administration (FDA) approval for a new artificial intelligence (AI) offering designed to detect low ejection fraction (EF).

Eko Health worked closely with Mayo Clinic to develop and evaluate its latest AI offering. “Importantly, since a stethoscope is small and portable, this technology can be used in urban and remote locations," one clinician said. 

Abbott has received approval from the U.S. Food and Drug Administration (FDA) for its TriClip transcatheter edge-to-edge repair (TEER) system designed to treat tricuspid regurgitation (TR).

Less than two months after an FDA advisory panel voted in favor of approval, the transcatheter edge-to-edge repair system can now be sold and marketed in the United States.

microsoft building

Buzzworthy developments of the past few days.

generative ai in education

The nation’s K-12 teachers and school administrators are intrigued by—yet anxious about—the advance of AI into their world.

Around the web

Within healthcare, artificial intelligence and quality improvement have some things in common. 

In a new report, the New York Times details multiple incidents of the insurance giant using legal threats to silence social media users and news outlets, citing the murder of Brian Thompson and the threat of rising violence as the basis for its claims. 

The Consumer Financial Protection Bureau joined trade lobby groups in asking a federal court to vacate the rule, which would have forbidden creditors from considering medical debt in lending decisions.